Status:
TERMINATED
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
Lead Sponsor:
Allergan
Conditions:
Spasmodic Torticollis
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck
Eligibility Criteria
Inclusion
- Diagnosed with cervical dystonia/spasmodic torticollis for at least 18 months
- Successfully treated previously with botulinum toxin type A
Exclusion
- Breast feeding, pregnant, or could become pregnant
- Surgery or spinal cord stimulation for cervical dystonia
- Previous injections of phenol, alcohol for cervical dystonia
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00432341
Start Date
June 1 2007
End Date
June 1 2009
Last Update
December 16 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Buenos Aires, Argentina
2
Parkville, Victoria, Australia
3
New Delhi, New Delhi, India